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Abstract
We report the case of a child with Noonan syndrome affected by 
hypertrophic cardiomyopathy and severe obstructive sleep apnea syndrome. 
The patient was born at 35 weeks gestational age (birth weight 3,340 g) and 
required mechanical ventilation. At the age of 4 years and 2 months, he was 
referred to our center for sleep cardiorespiratory polygraphy. His parents 
reported frequent obstructive sleep apnea, noisy respiration and snoring, oral 
breathing and falling asleep during the day. They were anxious that the child 
could die from asphyxiation during sleep. After the polygraph study had 
started, the patient began napping and immediately the polygraph showed 
several bouts of obstructive apnea and oxygen desaturation. He was referred 
for urgent adenotomy. At the age of 4 years and 5 months (3 months after 
surgery), the symptomatology and repeat sleep polygraph study showed a 
marked improvement. 
In conclusion, obstructive sleep apnea is a very hazardous condition for 
children with Noonan syndrome. They are a population at risk because of 
facial problems and cardiopathy. The real global incidence of obstructive 
sleep apnea syndrome in these children is unknown.
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Introduction
Obstructive sleep apnea syndrome (OSAS) is 
a condition of recurrent upper airway obstruction 
that leads to intermittent hypoxia, sleep disruption, 
learning disabilities and decreased somatic growth 
[1]. Overnight polysomnography is the only reliable 
tool that can differentiate OSAS from primary 
snoring [1]. Cardiovascular consequences are 
frequent in patients with OSAS [2]. 
Noonan syndrome (NS; OMIM 163950) is a 
genetically transmitted autosomal dominant disorder 
characterized by distinctive facial deformities, short 
stature, chest deformity and congenital heart disease 
[3]. The main facial features of NS are hypertelorism 
with down-slanting palpebral fissures, ptosis, and 
low-set posteriorly rotated ears with a thickened 
helix. Additional features are possible, such as a 
webbed neck, chest deformity, mild intellectual 
deficit, cryptorchidism, poor feeding in infancy, 
bleeding tendency, and lymphatic dysplasia [4]. The 
cardiovascular defects usually associated with this 
condition are pulmonary stenosis and hypertrophic 
cardiomyopathy [5]. The cardiological course may 
be stable or progressively worsening, or it may 
improve. Management is similar to that for any 
patient with hypertrophic cardiomyopathy [3]. 
We report the case of a child with NS affected 
by hypertrophic cardiomyopathy and severe OSAS. 
History and clinical considerations have been 
included.
Case report
The case study was based on pre-existing 
clinical practice, so that ethical permission and 
informed consent were unnecessary. The study was 
performed in accordance with the Declaration of 
Helsinki and under the terms of all relevant local 
legislation. Written informed consent was obtained 
from the patient’s parents for publication of this 
case report and any accompanying images.
Patient
The case patient was born at 35 weeks 
gestational age (birth weight 3,340 g) and required 
mechanical ventilation. His mother, father, 
and an older brother were healthy. He showed 
left ventricular hypertrophy, liver and spleen 
hypertrophy, cryptorchidism and bifid uvula. From 
the age of 2 years, he suffered from persistent 
sleep apnea, nasal obstruction, and frequent bouts 
of high airway infection. At the age of 2 years 
and 8 months, otorhinolaryngological evaluation 
disclosed adenoid hypertrophy. Since he was 
affected by cardiopathy, the anesthesiologist 
postponed the surgical intervention.
Physical examination and laboratory tests
At the age of 4 years and 2 months (body 
weight 15 kg, length 92 cm, BSA 0.6), he was 
referred to our center for cardiorespiratory 
portable polygraphy [6]. His parents had reported 
frequent obstructive sleep apnea (OSA) followed 
by unblocking of the airway, noisy respiration and 
snoring, oral breathing, and falling asleep during 
the daytime. They were anxious that the child 
could die from asphyxiation during sleep. After the 
polygraphy had started, the child began to nap and 
immediately the polygraph showed several bouts 
of obstructive apnea and oxygen desaturation. As 
a result, he was hospitalized.
His blood coagulation profile was normal. A 
chest X-ray showed heart hypertrophy (Fig. 1), 
and the polygraph was applied that same evening 
again to record for a full night (Tab. 1, Fig. 2A and 
Fig. 2B). Respiratory events were inspired by the 
American Academy of Sleep Medicine guidelines 
[7]. At the same time, he showed nocturnal (during 
sleep) pCO
2
 of 58 mmHg and HCO
3
 32 mmol/L 
and diurnal (wakeful) pCO
2
 of 41 mmHg and HCO
3
 
26 mmol/L. Otorhinolaryngological evaluation 
with nasal fiberoscopy confirmed severe adenoidal 
hypertrophy (grade IV) and bifid uvula. He was 
treated with C-PAP initially, and then with a high 
flow nasal cannula [8]. A cardiological ultrasound 
evaluation showed a left intraventricular gradient 
of 26 mmHg; left ventricle with basal hypertrophy 
of the septum (14 mm); systolic obstruction of 
the ventricular cavity; mild mitral and tricuspid 
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insufficiency; normal right ventricle function. He 
was referred for urgent adenotomy.
After surgery, the patient was extubated and 
awakened successfully in the Intensive Pediatric 
Care Unit. He showed a rapid improvement in 
sleep quality and sleep respiratory pattern, and was 
discharged.
At the age of 4 years and 5 months (3 months 
after surgery), a repeat sleep polygraph study 
Table 1. Summary of actigraphy and echocardiography 






AHI (events/h) 114 9
OA (events/h) 85 3
ODI (events/h) 101 8
Mean SpO2 (%) 93 96
Min SpO2 (%) 79 86
SpO2 < 90% (%) 21.3 0.4
Sleep pCO2 (mmHg) 58 41
Echocardiography
EDV (mL) 18 Unchanged
ESV (mL) 4 -
EF (%) 78 -
EDV (mL/mq) 30 -
ESV (mL/mq) 7 -
TAPSE (mm) 23 -
AHI: apnea-hypopnea index; OA: obstructive apnea; ODI: oxygen 
desaturation index; EDV: end-diastolic volume; ESV: end-systolic 
volume; EF: ejection fraction; TAPSE: tricuspid annular plane sys-
tolic excursion.Figure 1. Chest X-ray showing hypertrophic cardiopathy.
Figure 2. A. Four-hour cardiorespiratory polygraphy during sleep before surgery (from 11:50 PM to 3:30 AM). The graphic 
shows continuous respiratory events (blue = obstructive apneas, green = hypopneas) and desaturation (SpO2 events; red 
colors). B. Three-minute cardiorespiratory polygraphy during sleep before surgery. The graphic shows respiratory events 
(nasal flux; blue = obstructive apneas, green = hypopneas) and desaturations (SpO2 events; pink colors).
B.
A.
showed a significant improvement (Fig. 3A and 
Fig. 3B). Thyroid function was normal; screening 
for celiac disease was negative. Bone age evaluation 
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(right arm X-ray) showed a delay of skeletal growth 
with an age of 3 years. The cardiological evaluation 
showed the persistence of the intraventricular 
gradient, unchanged from that performed before 
surgery. Finally, his parents were now satisfied with 
how he slept.
Discussion
This is the second reported case of childhood 
NS showing severe OSAS and sleep hyper-
capnia which benefited from adenoidectomy. 
Previously, Khirani et al. [9] reported a 15-month-
old boy with OSAS and moderate hypertrophic 
cardiomyopathy initially treated with beta-
blockers (stopped 6 months after birth because 
of an improvement on ultrasonographic examina-
tion). In that case, because of important oxygen 
desaturation events during daytime napping, 
he was hospitalized, and his sleep pattern was 
assessed by overnight actigraphy. After surgery, 
he showed complete actigraphic recovery. Four 
months later, polysomnography during daytime 
napping confirmed the recovery [9]. In our 
case, clinical improvement was also excellent. 
Polygraphy, performed 3 months after surgery, 
although much improved, showed that the 
problem was not completely resolved. In many 
children with craniofacial disorders, soft tissue 
correction, for example by adenoidectomy, does 
not always fully remedy the airway obstruction 
[10], as in our case. Further assessment and 
longer follow-up are mandatory.
Clinical management of NS focuses on 
cardiological treatment and follow-up, monitoring 
of growth and development, and symptomatic 
intervention when required [11]. About 25% of 
patients die because of heart failure in the first year 
[5]. The potential for airway difficulties exists in 
NS due to aberrations in the airway such as a high 
palatal arch, dental malocclusion, and micrognathia 
in children [3]. Unfortunately, no data exist about 
the frequency of sleep respiratory disorders in 
these children. Therefore, polysomnography is 
indicated in children with congenital heart disease 
or craniofacial anomalies, such as in NS, with 
adenotonsillectomy as a possible option to treat 
OSAS [12]. 
The risk of complications due to the presence 
of severe OSA in patients with NS affected by 
cardiopathy outweighs the risk of perioperative 
and/or postoperative management. In general, 
Figure 3. A. Four-hour cardiorespiratory polygraphy during sleep 3 months after surgery (from 11:45 PM to 5:15 AM). 
The graphic shows significant improvement with regard to both respiratory events (blue = obstructive apneas, green = 
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OSAS negatively affects growth, neurocognitive 
function, and cardiovascular physiology [13], with 
higher pulmonary artery pressure and impaired 
right ventricular function [14]. The presence of 
hypertrophic obstructive cardiomyopathy renders 
these children susceptible to acute congestive heart 
failure due to hemodynamic fluctuations [15]. 
This study reports the first application of 
sleep respiratory polygraphy in a child with NS 
affected by OSAS and cardiopathy. In this case, 
previous anesthesiological evaluation indicated 
that surgery was necessary, but the polygraphic 
evaluation made surgical interven tion mandatory. 
Polysomnography should be performed in children 
with cardiopathy, such as those with NS, to provide 
a full assessment of the sleep respiratory status 
before surgery. The cardiovascular consequences 
of OSAS and the congenital cardiopathy amplified 
each other and resulted in both short- and long-term 
adverse cardiovascular outcomes. A limitation of 
this study is the failure of the full polysomnography 
recording (with EEG).
OSAS is prevalent in two peak periods. The 
first occurs in children from 2 to 8 years of age, 
with the presence of an enlarged adenoid and/or 
tonsils. Approximately 0.5-1% of all children will 
have clinically relevant OSA [16]. Moreover, NS 
has an estimated prevalence of 1 in 1,000 to 2,500 
live births [3]. In Italy, there were 474,000 live 
births in 2016. If the two events are independent 
of each other, and if the incidence of OSAS in NS 
is the same as in the general population, 1-2 NS 
neonates per year in Italy will develop OSAS.
Conclusion
OSA must be treated promptly in children with 
NS. They are a population at risk because of facial 
problems and cardiopathy. The clinical situation 
significantly improved with adenotomy, but the 
patient requires strict follow-up after surgery. The 
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